Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024)

Molecular Partners Ag (MOLN) posted quarterly Change in Intangibles of $18447.7 for Q3 2024, down 89.61% year-on-year from $177497.7 in Q4 2023, and up 204.33% on a QoQ basis from -$17682.7 in Q2 2024.

Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Change in Intangibles for 4 consecutive years, with $18447.7 the latest figure, recorded in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -66,508.31
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 18,447.69
Sep 30, 2024 18,447.69
Jun 30, 2024 -17,682.74
Jun 30, 2024 -17,682.74
Mar 31, 2024 -10.31
Mar 31, 2024 -10.31
Sep 30, 2023 177,497.75
Sep 30, 2023 177,497.75
Jun 30, 2023 -174,505.90
Jun 30, 2023 -174,505.90
Mar 31, 2023 -102.71
Mar 31, 2023 -102.71
Sep 30, 2022 113,715.92
Sep 30, 2022 113,715.92
Jun 30, 2022 -114,245.46
Jun 30, 2022 -114,245.46
Mar 31, 2022 34.65
Mar 31, 2022 34.65
Sep 30, 2021 200,142.72
Sep 30, 2021 200,142.72